Revised criteria for neuromyelitis optica - A new diagnostic standard? Commentary

Nature Clinical Practice Neurology

Volumn 3, Issue 3, 2007, Pages 132-133

  Hemmer, Bernhard ^a   Stüve, Olaf ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4; IMMUNOGLOBULIN G ANTIBODY;

DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; HUMAN; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; OPTIC NEURITIS; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; SPINAL CORD; SPINAL CORD LESION; UNITED STATES;

EID: 33947182607     PISSN: 1745834X     EISSN: 17458358     Source Type: Journal    
DOI: 10.1038/ncpneuro0420     Document Type: Short Survey

References (6)

1. Lucchinetti CF et al. (2002) A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 125: 1450-1461
2. Cree BA et al. (2005) An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64: 1270-1272
3. Lennon VA et al. (2004) A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 364: 2106-2112
4. Lennon VA et al. (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202: 473-477
5. Wingerchuk DM et al. (1999) The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53: 1107-1114
6. Bielekova B and Martin R (2004) Development of biomarkers in multiple sclerosis. Brain 127: 1463-1478